NCT03104946

Brief Summary

From November 2014 to October 2015, a multi-centers retrospective study was conducted to collect compliance, and 8 three-level hospitals from China were included. The infants survived to a postmenstrual age of 36 week with birth weight less than 1500g and without congenital disease. The birth weight, gestational age, morbidities and poor outcomes( death, cerebral palsy, cognitive, et al) were recorded. Data were analyzed with Chi-square test to observe the relationship between morbidities and poor outcomes. And the predictive effect on the number of the top three morbidities were analyzed by Logistic regression analysis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
834

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2013

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 7, 2017

Completed
Last Updated

April 7, 2017

Status Verified

March 1, 2017

Enrollment Period

2.2 years

First QC Date

March 28, 2017

Last Update Submit

April 2, 2017

Conditions

Outcome Measures

Primary Outcomes (3)

  • cognitive delay

    mental development index(MDI)\<70

    1 year

  • hearing impairment

    do not pass auditory brainstem response (ABR)

    1 year

  • visual impairment

    do not pass okineticnystagmus

    1 year

Study Arms (8)

Bronchopulmonary Dysplasia

Diagnostic Test: Mental Development Index;Auditory Brainstem Response;okineticnystagmus

Retinopathy

Diagnostic Test: Mental Development Index;Auditory Brainstem Response;okineticnystagmus

Severe Retinopathy

Diagnostic Test: Mental Development Index;Auditory Brainstem Response;okineticnystagmus

Neonatal Necrotizing Enterocolitis

Diagnostic Test: Mental Development Index;Auditory Brainstem Response;okineticnystagmus

Brain injury

Diagnostic Test: Mental Development Index;Auditory Brainstem Response;okineticnystagmus

sepsis

Diagnostic Test: Mental Development Index;Auditory Brainstem Response;okineticnystagmus

Patent Ductus Arteriosus

Diagnostic Test: Mental Development Index;Auditory Brainstem Response;okineticnystagmus

Respiratory Distress Syndrome

Diagnostic Test: Mental Development Index;Auditory Brainstem Response;okineticnystagmus

Interventions

mental development index(MDI)\<70:cognitive delay do not pass auditory brainstem response(ABR):hearing impairment do not pass okineticnystagmus:visual impairment Patent Ductus Arteriosus

Brain injuryBronchopulmonary DysplasiaNeonatal Necrotizing EnterocolitisPatent Ductus ArteriosusRespiratory Distress SyndromeRetinopathySevere Retinopathysepsis

Eligibility Criteria

Age1 Month - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

From November 2014 to October 2015, a multi-centers retrospective study was conducted to collect compliance, and 8 three-level hospitals from China were included. The infants survived to a postmenstrual age of 36 week with birth weight less than 1500g and without congenital disease.

You may qualify if:

  • From November 2014 to October 2015, a multi-centers retrospective study was conducted to collect compliance, and 8 three-level hospitals from China were included. The infants survived to a postmenstrual age of 36 week with birth weight less than 1500g.

You may not qualify if:

  • The very low birth weight infants didn't have any congenital disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF; Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA. 2003 Mar 5;289(9):1124-9. doi: 10.1001/jama.289.9.1124.

    PMID: 12622582BACKGROUND
  • Rao YB, Yang J, Cao B, Chen DM, Gao PM, Zhong Q, Li MX, Gao JH, Chen YJ, Zhong XM, Ren ZX. [Predictive effect of neonatal morbidities on the poor outcomes at 12 months corrected age in very low birth weight premature infants]. Zhonghua Er Ke Za Zhi. 2017 Aug 2;55(8):608-612. doi: 10.3760/cma.j.issn.0578-1310.2017.08.012. Chinese.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of Dept of Neonatology

Study Record Dates

First Submitted

March 28, 2017

First Posted

April 7, 2017

Study Start

September 1, 2013

Primary Completion

November 30, 2015

Study Completion

November 30, 2016

Last Updated

April 7, 2017

Record last verified: 2017-03